GlassScriptPhysician profile
Molly C Strong
NPI 1366760332
$1,037.27
in general payments reported to CMS, 2019-2025
24 companies · $456 in 2025
The $456 reported for 2025 was more than what 78% of Obstetrics & Gynecology providers received nationally (typical 2025 total: $158).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $89.90 · 2020: $77.54 · 2021: $170 · 2022: $115 · 2023: $94.14 · 2024: $34.43 · 2025: $456.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $500 · Education: $84.99.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $499.74 |
| Education | $84.99 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbvie INC. | $224.96 | 2019-2023 | Liletta |
| Astellas Pharma US INC | $213.81 | 2024-2025 | Veozah |
| Coopersurgical, INC. | $84.70 | 2019-2025 | Paragard T 380a, Paragard T 380a |
| Biogen, INC. | $67.88 | 2025 | Zurzuvae |
| Organon LLC | $44.47 | 2021-2025 | Jada System |
| Exeltis, USA INC. | $43.09 | 2019-2025 | Slynd |
| Hologic Sales and Service, LLC | $42.38 | 2021-2025 | Fluent Fluid Management System |
| Exact Sciences Corporation | $38.97 | 2025 | The Cologuard Plus Collection Kit, Cologuard Collection Kit |
| Therapeuticsmd, INC. | $27.34 | 2021-2022 | |
| Minerva Surgical, INC | $22.71 | 2020-2021 | |
| Mylan Pharmaceuticals INC. | $20.96 | 2022 | |
| Ethicon US, LLC | $20.66 | 2025 | Ethicon, Vistaseal, Dermabond |
| Boston Scientific Corporation | $19.24 | 2021 | |
| Davol INC. | $18.94 | 2022 | |
| Meditrina | $18.90 | 2021 |
Show all 24 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Agile Therapeutics, INC. | $17.23 | 2022 | |
| Millicent US INC | $15.60 | 2025 | Femlyv |
| Pfizer INC. | $15.52 | 2023 | |
| Abbott Laboratories | $14.31 | 2019 | |
| Sumitomo Pharma America, INC. | $13.84 | 2025 | Myfembree |
| Bayer Healthcare Pharmaceuticals INC. | $13.76 | 2023 | |
| Allergan, INC. | $13.11 | 2019 | |
| Optumhealth Care Solutions, LLC | $12.72 | 2023 | Vivify Health Care Team Portal |
| Mayne Pharma Commercial LLC | $12.17 | 2025 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Molly Strong listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.